Amniotic membrane is the innermost layer of the placenta, which finds extensive application in would healing and management. It acts as a biological bandage helping in fast healing of wounds, tissue repairing, and reduction in scarring. Amniotic membrane mimics the basement membrane in human tissues, thereby enabling smooth epithelialization and keratinization of wounds. Moreover, it provides anti-inflammatory, anti-bacterial and anti-scarring properties. Rising prevalence of chronic wounds such as diabetic foot ulcers has propelled the demand for amniotic membrane products.
The global Amniotic Membrane Market is estimated to be valued at US$ 3.62 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing prevalence of diabetes across the globe is a major factor driving the growth of the amniotic membrane market. According to the International Diabetes Federation, around 463 million adults were living with diabetes in 2019, and the number is expected to rise to 700 million by 2045. Diabetes contributes to various complications including diabetic foot ulcers which do not heal easily. Amniotic membrane provides an ideal environment for wound healing and is widely used for management and treatment of diabetic foot ulcers. Moreover, its anti-inflammatory, anti-bacterial and anti-scarring properties aid faster wound healing. Thus, growing incidence of diabetes will augment the demand for amniotic membrane products for treatment of chronic diabetic ulcers over the forecast period.
Segment Analysis
The global amniotic membrane market is segmented based on type, application, end-user, and geography. Based on type, the market is segmented into lyophilized amniotic membrane and cryopreserved amniotic membrane. Cryopreserved amniotic membrane dominated the segment in 2022 as it has a longer shelf-life and can be stored for a longer period as compared to lyophilized amniotic membrane. Based on application, the market is segmented into surgical wounds, ophthalmology, and others. The ophthalmology segment dominated the market in 2022 as amniotic membrane is widely used for ocular surface reconstruction in conditions like pterygium, corneal ulcers & wounds, and conjunctival tumors.
Key Takeaways
The global amniotic membrane market is expected to witness high growth during the forecast period of 2023 to 2030. The market size was valued at US$ 3.62 billion in 2024 and is projected to reach US$ 11.09 billion by 2030, registering a CAGR of 13% during the forecast period.
Regional analysis
North America dominated the global amniotic membrane market in 2024 and is expected to continue its dominance during the forecast period. The rising prevalence of ophthalmic disorders and increasing adoption of advanced wound care therapies are some of the key factors driving the market in the region. Asia Pacific is expected to be the fastest-growing market during the forecast period owing to large patient population, increasing healthcare expenditure, and growing medical tourism in counties like India and China.
Key players
Key players operating in the amniotic membrane market are Smith & Nephew, MiMedx, Integra LifeSciences Corporation, Stryker, Mölnlycke Health Care AB, Organogenesis Inc., Katena Products Inc., Skye Biologics Inc., LifeCell International Pvt. Ltd., and Surgenex LLC. Smith & Nephew dominated the global market share in 2024 owing to its wide product portfolio and geographical presence across major markets.
No comments:
Post a Comment